High levels of interleukin-6 in the exhaled breath condensate of patients with COPD

Respir Med. 2003 Dec;97(12):1299-302. doi: 10.1016/j.rmed.2003.07.008.

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation of the respiratory tract.

Methods: We investigated the presence of interleukin-6 (IL-6: a cytokine secreted by monocytes/macrophages, T cells, B cells, fibroblasts, bone marrow stromal cells, keratinocytes and endothelial cells) in the exhaled breath condensate of 16 exsmokers with moderate COPD, 12 healthy non-smokers. IL-6 was measured by means of a specific enzyme immunoassay.

Results: IL-6 levels were detectable in all of the subjects, but were higher in the COPD patients (8.0 +/- 0.1 pg/ml; P < 0.0001) than in the healthy non-smokers (4.9 +/- 0.2 pg/ml) with a correlation in this group between age and IL-6 levels (r = 0.597; P < 0.05).

Conclusions: The increased IL-6 levels in exhaled breath condensate may reflect airway inflammation in patients with COPD.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Breath Tests / methods
  • Female
  • Humans
  • Immunoenzyme Techniques / methods
  • Immunoenzyme Techniques / standards
  • Interleukin-6 / analysis*
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Reproducibility of Results
  • Smoking / metabolism

Substances

  • Biomarkers
  • Interleukin-6